Biosimilar cell lines

Ready to go, high expressing manufacturing biosimilar cell lines ready for development.

Polpharma Biologics has developed a portfolio of high producing cell lines expressing biosimilar proteins, such as fusion proteins, enzymes and monoclonal antibodies which are available for out-licensing.

These biosimilar cell lines are generated on our proprietary CHO-based platform, CHO^BC® using (animal component free) of the shelf culture medium.

The cell lines are GMP-ready, stable, high producing, fully documented and functionally characterized. All available QA approved documentation is accessible for our (potential) partners via a virtual data room.

Biosimilar programs are ready for tech transfer to a CMO of your choice or you can use our own CDMO services to advance to the clinic rapidly. Our cell lines and programs in different development stages, can be found in the table below. If a biosimilar that you are interested in is not listed contact us as we may have it in late stage development or can develop a cell line for you.

Cell lines available today

Biosimilar to	Antibody
Herceptin®	Trastuzumab
Humira®	Adalimumab
Erbitux®	Cetuximab
Avastin®	Bevacizumab
Rituxan/MabThera®	Rituximab
Enbrel®	Etanercept
Synagis®	Palivizumab
Xolair®	Omalizumab
Yervoy®	Ipilimumab
Perjeta®	Pertuzumab
Opdivo®	Nivolumab
Keytruda®	Pembrolizumab

When: Jun 14 - 17 2021

Where: Digital

BIO International Convention

More information about the 2021 event will be made available in the coming months.

When: Mar 22 - 25 2021

Where: Digital

Bio Europe Spring 2021

The fifteenth annual BIO-Europe Spring® premier springtime partnering conference will be held March 22-25 in a fully...

Corporate & Site tours

Published: 08.12.2020

Introduction to our microbial solutions

We offer fully integrated biopharmaceutical solutions for microbial products. From tech transfer to clinical supply i...

Corporate & Site tours

Published: 08.12.2020

Polpharma biologics Utrecht facility

Located in the Utrecht Science Park, a hub for education, research, entrepreneurship and healthcare. The state-of-the...

Development & manufacturing solutions

Published: 08.12.2020

Introduction to our cell line development platform

Our proprietary CHOBC® expression platform allows rapid generation of high-quality cell lines with a completely anima...

Portfolio & partnerships

Published: 08.12.2020

Novel biologics and biosimilars pipeline and portfolio

Polpharma Biologics has its own pipeline of biosimilar and novel therapeutics for out-licensing. We are focused on ad...

Learn more

Let’s collaborate and create quality biologics together.

Get in touch for more information.

Biosimilar cell lines

Cell lines available today

Related material

Let’s collaborate and create quality biologics together.